Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,415,287,594
+$684,255,621 QoQ
Shares Held
2,013,696
+7.0% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#44
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Asset Management Co., Ltd. holds $7,515,796,384 across 13 Drug Manufacturers - General names. LLY ranks #1 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,013,696 | $2,415,287,594 | |
| 2 | JNJ |
Johnson & Johnson
|
6,075,370 | $1,542,961,718 | |
| 3 | ABBV |
AbbVie Inc.
|
4,340,720 | $1,092,298,780 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,184,340 | $794,687,690 | |
| 5 | AMGN |
Amgen Inc
|
1,478,418 | $535,364,726 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,157,393 | $398,905,031 | |
| 7 | PFE |
Pfizer Inc
|
14,060,742 | $338,582,667 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,540,268 | $319,230,242 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,415,287,594 | 2,013,696 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,731,031,973 | 1,882,027 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,882,061,466 | 1,751,276 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,262,131,710 | 1,654,170 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,228,725,587 | 1,576,239 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,216,178,078 | 1,472,531 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,006,681,824 | 1,303,992 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,033,630,627 | 1,166,705 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $978,021,353 | 1,080,233 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $744,215,985 | 956,625 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $462,282,957 | 793,047 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $399,360,452 | 743,508 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $327,107,453 | 697,487 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $222,788,573 | 648,735 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $215,196,599 | 588,226 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $168,945,848 | 522,486 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $154,522,830 | 476,584 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $126,568,094 | 441,974 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $111,108,942 | 402,248 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $79,572,233 | 344,394 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $72,542,091 | 316,060 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $53,811,819 | 288,041 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $43,581,656 | 258,124 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $36,793,627 | 248,572 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $36,055,569 | 219,610 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $27,901,863 | 201,138 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||